Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Validation of the REMINDER Dementia Risk Reduction Program

Validation of a Multidomain Neuropsychological Intervention for Individuals at Risk of Dementia: the REMINDER Program

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Until now, neuropsychological interventions aimed to optimize cognitive function and to have functional impact in individuals at risk of AD (MCI patients) were scarce in validity studies. While some RCTs have been developed in cognitive training interventions, comparative studies of merged interventions (cognitive, social and behavioral stimulation) with adequate control groups are absent, diminishing the professionals' trust on the adoption of these interventions for supporting patients. As such, the present proposal will develop a validation trial testing a multicomponent neuropsychological intervention (REMINDER), based on personal development, cognitive compensatory aids, meaningful goals setting, and behavior change techniques. The investigators will analyze its short/long-term gains and AD conversion rates. By aiming to provide a good validation study for REMINDER, the investigators will examine neurobiological, neurocognitive and functional outcomes of this intervention in comparison with an active control group (psychoeducation) in order to foster an effective outcome assessment of an intervention for individuals at risk of AD.

Who May Be Eligible (Plain English)

Who May Qualify: - Age 60 or older - CAIDE dementia risk score \>8 - Cognitive function: absence of significant cognitive impairment as per the Addenbrooke's Cognitive Examination-REVISED - Free of physical disabilities that preclude participation in the study - Willing to complete all study-related activities for 12 weeks Who Should NOT Join This Trial: - Mild cognitive impairment or dementia; - Presence of any neurological event in their medical history that could compromise actual cognition. - Presence of any severe psychiatric disorder (mild depressive and anxiety symptoms meet inclusion criteria). - Unability to travel to the site where the sessions will be delivered (if so randomization will be circumscribed between the experimental harm REMINDER online and the control group. - Illiteracy Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age 60 or older * CAIDE dementia risk score \>8 * Cognitive function: absence of significant cognitive impairment as per the Addenbrooke's Cognitive Examination-REVISED * Free of physical disabilities that preclude participation in the study * Willing to complete all study-related activities for 12 weeks Exclusion Criteria: * Mild cognitive impairment or dementia; * Presence of any neurological event in their medical history that could compromise actual cognition. * Presence of any severe psychiatric disorder (mild depressive and anxiety symptoms meet inclusion criteria). * Unability to travel to the site where the sessions will be delivered (if so randomization will be circumscribed between the experimental harm REMINDER online and the control group. * Illiteracy

Treatments Being Tested

BEHAVIORAL

REMINDER

The REMINDER program is a therapist-mediated manualized neuropsychological intervention, involving training skills to stimulate cognitive reserve, socialization and personal development, to diminish the risk of cognitive decline.

BEHAVIORAL

Brain health Psychoeducation

Delivery of psychoeducation sessions about dementia modifiable risk factors, brain health solutions and lifestyle change tips.

Locations (1)

Faculty of Psychology and Educational Sciences
Coimbra, Portugal